How digital therapeutics are revolutionising healthcare
June 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma
Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies
June 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics
Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …
Number of people waiting for NHS treatment could double to 10 million due to pandemic
June 10, 2020Research and Development COVID-19, coronavirus
The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …
Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents
June 10, 2020Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma
Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
Pharmafile.com’s weekly COVID-19 news round-up
June 10, 2020Research and Development COVID-19, coronavirus, round up, top 10
Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …
Lundbeck to restructure R&D, shedding up to 160 jobs
June 10, 2020Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …
US trial of ivermectin cuts coronavirus mortality by 40%
June 10, 2020Research and Development COVID-19, coronavirus
A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …
EMA could approve Gilead’s streamlined remdesivir application for COVID-19 “within weeks”
June 9, 2020Manufacturing and Production, Sales and Marketing COVID-19, EU, Gilead, coronavirus, remdesivir
The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …
Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1
June 9, 2020Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease
Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …
Coronavirus lockdowns prevented 3.1 million deaths throughout Europe, according to new study
June 9, 2020Manufacturing and Production COVID-19, coronavirus, pandemic
The widespread lockdowns implemented throughout Europe are estimated to have prevented 3.1 million deaths from the COVID-19 pandemic. This is …
COVID-19 could have emerged in Wuhan as early as August, new study speculates
June 9, 2020Manufacturing and Production COVID-19, Wuhan, coronavirus
Coronavirus may have been spreading throughout Wuhan in August 2019, according to a new study. This research was carried out …
FDA launches new pilot program to crack down on unapproved opioids sold online
June 9, 2020Manufacturing and Production FDA, opiod crisis, opioids
The FDA is collaborating with the National Telecommunications and Information Administration (NTIA) to launch a pilot program to reduce the …
AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients
June 8, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma
AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic
June 8, 2020Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic
Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …
US supply of Gilead’s remdesivir expected to run out by the end of June
June 8, 2020Sales and Marketing
The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the …
Oxford Biomedica joins forces with UK’s Vaccines Manufacturing and Innovation Centre to scale up production of Oxford Uni’s COVID-19 vaccine
June 8, 2020Manufacturing and Production, Sales and Marketing COVID-19, Oxford BioMedica, University of Oxford, Vaccine, coronavirus, pharma
Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …
Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk
June 8, 2020Sales and Marketing COVID-19, coronavirus, drugs
The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …
Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen
June 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients
June 5, 2020Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir
Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …
British COVID-19 test-and-trace system will not be fully operational until September, despite it launching last month
June 5, 2020Medical Communications COVID-19, NHS, coronavirus
The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
